Back to Search
SHENG SI, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1396126215IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
275284(MA)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
In situ synthesis of shape-selective gold nanocrystals using oligopeptide template: effect of various reaction parameters.
PMID 19198329·J Nanosci Nanotechnol·2008
8-other
Reversible self-assembly of carboxylated peptide-functionalized gold nanoparticles driven by metal-ion coordination.
PMID 18615416·Chemphyschem·2008
8-other
Tryptophan-based peptides to synthesize gold and silver nanoparticles: a mechanistic and kinetic study.
PMID 17245786·Chemistry·2007
8-other
In situ synthesis of gold and silver nanoparticles by using redox-active amphiphiles and their phase transfer to organic solvents.
PMID 17960550·Chemistry·2007
8-other
The effect of substituted thiophene and benzothiophene derivates on PPARgamma expression and glucose metabolism.
PMID 19663652·J Enzyme Inhib Med Chem·2010
7-preclinical
The molecular target of rubimaillin in the inhibition of lipid droplet accumulation in macrophages.
PMID 19652367·Biol Pharm Bull·2009
7-preclinical
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells.
PMID 18930459·Atherosclerosis·2009
7-preclinical
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
PMID 19059538·Metabolism·2009
7-preclinical
Photorefractive dynamic properties of Ca2+-doped strontium barium niobate crystals.
PMID 19137024·Appl Opt·2009
8-other
Characterization of the isoflavone pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells.
PMID 19571401·Biol Pharm Bull·2009
8-other
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
PMID 18523770·Cancer Immunol Immunother·2009
7-preclinical
Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor.
PMID 19524435·Bioorg Med Chem Lett·2009
7-preclinical
Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library.
PMID 18594022·J Biomol Screen·2008
8-other
Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening.
PMID 18723485·Mol Cancer Ther·2008
8-other
Novel ascorbic acid based ionic liquids for the in situ synthesis of quasi-spherical and anisotropic gold nanostructures in aqueous medium.
PMID 18470852·Chemistry·2008
8-other
Molecular target of piperine in the inhibition of lipid droplet accumulation in macrophages.
PMID 18520030·Biol Pharm Bull·2008
7-preclinical
The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
PMID 18575744·Oncol Rep·2008
8-other
Isolation and characterization of antibiotic NC0604, a new analogue of bleomycin.
PMID 19194033·J Antibiot (Tokyo)·2008
8-other
[Adenovirus mediated targeted genetherapy of Staphylococcal enterotoxin A and CD80 for hepatoma and its primary immune mechanisms].
PMID 18328193·Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 ALBANY STREET, 9TH FLOOR, SUITE 9B
BOSTON, MA 02118 - Phone
- (617) 638-4860
Quick Facts
- NPI
- 1396126215
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile